{
    "nctId": "NCT01164930",
    "briefTitle": "Impact of Acceptance and Commitment Therapy on Early Stage Breast Cancer",
    "officialTitle": "Impact of Acceptance and Commitment Therapy on Salivary Cortisol in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Survivorship, Stress",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "salivary cortisol",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of stage I-III breast cancer\n* prescreen distress score above defined cutoff\n* agreement not to seek other breast cancer support services until study completion\n\nExclusion Criteria:\n\n* previous cancer\n* prior psychiatric treatment for serious mental health disorder (e.g., hospitalization or formal diagnosis of psychosis, major depressive episode, borderline mental retardation, suicidality, or current substance dependence)\n* current use of medications known to interfere with cortisol levels (e.g., dexamethasone)\n* major concurrent medical disease",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}